Skip to main content

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Introduction

On Monday, September 9, the trial over claims that Johnson & Johnson’s (J&J) talc-based baby powder that caused ovarian cancer to a woman is set to begin in Atlanta. In the first case of its kind, Georgia jurors will have a chance to find a link between talcum powder and ovarian cancer.

A trial before Judge Jane Morrison involves the lawsuit filed by an Atlanta resident who died of ovarian cancer in 2016 at the age of 65. The woman filed a lawsuit against J&J shortly before her death. Her adopted minor granddaughter is the named plaintiff in this case.

Georgia jury will see evidence on how the use of talcum powder products for feminine hygiene can result in ovarian cancer. The trial is expected to continue for two weeks. As of February 2016, in seven different trials in Missouri and California juries have awarded more than $5.3 billion in damages against J&J.

From decades, studies have examined the link between genital talc use and ovarian cancer. The research shows that talc particles can migrate into the ovaries, causing inflammation and leading to the growth of malignant cells resulting in ovarian cancer. 

Talcum powder allegations include that the company knew about the risks of using talcum powder for decades and failed to warn the public of the potential risk of ovarian cancer in women despite numerous scientific studies suggesting talc as a cancer-causing mineral. Rather, they chose to market the talcum powder products to women and children for hygienic use despite being aware of the risks desiring profits before consumer safety. Lawsuits also claim J&J hid the fact that talcum powder contains asbestos.

Talc defendants currently face nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits, consolidated under multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), in the District of New Jersey. The MDL is presided by Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.